Article
Can botulinum toxin put the restless legs syndrome to rest?
Medical hypotheses - 1 Jan 2007
Lim Erle C H, Seet Raymond C S
Abstract excerpt
The restless legs syndrome (RLS), affecting between 3% and 15% of the population, is characterised by an urge to move the legs during wakefulness, associated with a range of unpleasant sensory symptoms, especially when sitting or lying down at night. The symptoms can even be painful, and lead to sleep disturbances and depression. RLS is treated with dopaminergic agents, anticonvulsants, opioids, clonidine and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
